Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Calcium dobesilate |
EINECS | 243-531-5 |
CAS No. | 20123-80-2 | Density | N/A |
PSA | 212.08000 | LogP | 2.16540 |
Solubility | N/A | Melting Point |
>300° (dec) |
Formula | C12H10Ca2O10S2 | Boiling Point | N/A |
Molecular Weight | 418.415 | Flash Point | N/A |
Transport Information | N/A | Appearance | white or almost powder |
Safety | 26 | Risk Codes | 36/37/38 |
Molecular Structure | Hazard Symbols | Xi | |
Synonyms |
2,5-Dihydroxybenzenesulfonicacid calcium salt;Calcium 2,5-dihydroxybenzenesulfonate;Calciumbis(2,5-dihydroxybenzenesulfonate);Calcium Doxybensylate;benzenesulfonic acid, 2,5-dihydroxy-, calcium salt (2:1); |
Article Data | 1 |
Molecular Structure of Calcium dobesilate (CAS NO.20123-80-2):
IUPAC Name: calcium 2,5-dihydroxybenzenesulfonate
Empirical Formula: C12H10Ca2O10S2
Molecular Weight: 418.4098
ACD/LogP: -1.35
of Rule of 5 Violations: 0
ACD/LogD (pH 5.5): -4.85
ACD/LogD (pH 7.4): -4.85
ACD/BCF (pH 5.5): 1
ACD/BCF (pH 7.4): 1
ACD/KOC (pH 5.5): 1
ACD/KOC (pH 7.4): 1
H bond acceptors: 5
H bond donors: 3
Freely Rotating Bonds: 3
Polar Surface Area: 81.21Å2
EINECS: 243-531-5
Classification Code:Coagulants ; Drug / Therapeutic Agent ; Hematologic Agents ; Hemostatics
Synonyms of Calcium dobesilate (CAS NO.20123-80-2): benzenesulfonic acid, 2,5-dihydroxy-, calcium salt (2:1) ; Calcium bis(2,5-dihydroxybenzenesulfonate) ; Calcium Doxybensylate ; 2,5-Dihydroxybenzenesulfonic acid calcium salt
guinea pig | LD50 | oral | 4979mg/kg (4979mg/kg) | AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: EXCITEMENT | Toksikologicheskii Vestnik. Vol. (1), Pg. 29, 1994. |
mouse | LD50 | intraperitoneal | 876mg/kg (876mg/kg) | AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: EXCITEMENT | Toksikologicheskii Vestnik. Vol. (1), Pg. 29, 1994. |
mouse | LD50 | intravenous | 775mg/kg (775mg/kg) | Annales Pharmaceutiques Francaises. Vol. 30, Pg. 415, 1972. | |
mouse | LD50 | oral | 7549mg/kg (7549mg/kg) | AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: EXCITEMENT | Toksikologicheskii Vestnik. Vol. (1), Pg. 29, 1994. |
mouse | LD50 | unreported | 700mg/kg (700mg/kg) | United States Patent Document. Vol. #3509207, | |
rat | LD50 | intravenous | 750mg/kg (750mg/kg) | United States Patent Document. Vol. #4513007, | |
rat | LD50 | oral | 7061mg/kg (7061mg/kg) | AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: EXCITEMENT | Toksikologicheskii Vestnik. Vol. (1), Pg. 29, 1994. |
Moderately toxic by intravenous route. Mildly toxic by ingestion. When heated to decomposition it emits toxic fumes of SOx. See also SULFONATES and CALCIUM COMPOUNDS.
Calcium dobesilate (CAS NO.20123-80-2) is a white crystalline powder, as a nutritional medicine for microvascular.